Gut Health and Parkinson's Disease: A Hidden Connection
New research links gut microbiome to Parkinson's disease progression.
Livia H. Morais, Linsey Stiles, Milla Freeman, Anastasiya D. Oguienko, Jonathan D. Hoang, Jeff Jones, Baiyi Quan, Jack Devine, Justin S. Bois, Tsui-Fen Chou, Joanne Trinh, Martin Picard, Viviana Gradinaru, Sarkis K. Mazmanian
― 7 min read
Table of Contents
- Non-Motor Symptoms of Parkinson's Disease
- The Role of Gut Microbiome in Parkinson's Disease
- Exploring the Impact of Gut Microbiome on Motor Symptoms
- The Connection Between Mitochondria and Gut Microbiome
- Investigating the Effect of Oxidative Stress
- Mitochondrial Behavior in Mice with PD
- Possible Links to Treatment
- Conclusion
- Original Source
- Reference Links
Parkinson's Disease (PD) is the second most common brain disorder that affects people as they age, particularly those over 60 years old. It impacts about 1% of this age group in the United States. This condition is known for causing motor problems like stiffness, shaking, and issues with balance. One main culprit behind PD is the buildup of a protein called alpha-synuclein (α-syn). This buildup leads to the death of important brain cells, particularly those that produce dopamine, a chemical crucial for movement and coordination.
While scientists continue to investigate what causes PD, there's a significant amount of evidence suggesting that problems with tiny energy factories in our cells called mitochondria play a role. These mitochondria are responsible for producing energy and keeping cells healthy. Certain genetic mutations that affect mitochondrial proteins have been linked to forms of PD that run in families.
In people with PD, the mitochondria often have trouble doing their job, which can lead to increased damage from stressors, known as Oxidative Stress. This stress can further harm neurons, contributing to the symptoms of the disease. Interestingly, studies have shown that mitochondrial function is impaired in tissues from a specific part of the brain affected by PD.
The research also found that exposure to certain toxins that interfere with mitochondrial function can cause similar brain damage and motor issues in animals. Additionally, new genetic models of PD have shown that when certain mutations are present, they can lead to conditions resembling PD.
Non-Motor Symptoms of Parkinson's Disease
Although Parkinson's is primarily seen as a disorder affecting movement, many patients report experiencing non-motor symptoms too. These include issues with sleep, a reduced sense of smell, and gastrointestinal problems like constipation and stomach pain, often appearing years before any official diagnosis of PD.
A theory proposed by scientists suggests that changes in the gut may be one of the first places where the disease starts. Specifically, the buildup of α-syn might begin in the intestines, then travel to different parts of the brain via the vagus nerve, which connects the gut and brain. Experiments where scientists injected α-syn into animals' intestines have led to both gut problems and brain damage over time.
Researchers have also found that surgical procedures to cut the vagus nerve can stop the disease's progression in animal models. Similarly, studies in humans have shown that people who have had this surgery may have a lower risk of developing PD. Furthermore, inflammation in the intestines may make symptoms worse. This suggests that in some cases, PD might start in the gut rather than the brain.
Gut Microbiome in Parkinson's Disease
The Role ofScientists have observed that the gut microbiome – the collection of bacteria and other microorganisms living in our intestines – is different in people with PD compared to healthy individuals. These differences include a decrease in beneficial bacteria and an increase in bacteria that promote inflammation.
Research has shown that the gut microbiome can influence how well someone can move, how the gut functions, and even the progression of α-syn pathology in animal models of PD. Some harmful bacteria can worsen the disease, while treatments that restore a healthy microbiome can improve movement in animals.
One curious finding is that when gut microbiota from PD patients is transferred into mice with altered α-syn levels, the mice experience increased motor difficulties. However, when a healthy microbiome is used for the same procedure, the mice do not show as severe symptoms. This suggests that the microbiome may play a role in the development of PD and could be a target for new treatments.
Exploring the Impact of Gut Microbiome on Motor Symptoms
A recent study focused on the idea that the gut microbiome can affect motor symptoms in mice that overexpress α-syn. The results showed that changes in the gut microbiome can impact energy production and stress levels in the brain, leading to motor issues in the mice.
Interestingly, when analyzing the brains of mice without gut bacteria, researchers found they did not show the usual motor symptoms tied to α-syn. These findings point to the microbiome’s significant role in generating energy within the brain, a process crucial for proper functioning.
When researchers examined the energy production in the brains of these mice, they found that those with a typical microbiome had better mitochondrial function compared to those without bacteria. This suggests that the microbiome may help regulate how well mitochondria perform their energy-producing tasks, impacting overall motor abilities.
The Connection Between Mitochondria and Gut Microbiome
Mitochondria are essential for generating energy in our cells, and their health is crucial for normal brain function. An unhealthy microbiome can interfere with mitochondrial function, leading to increased oxidative stress and energy deficits in the brain.
Researchers discovered that specific genes related to energy production were changed in the brains of mice with a conventional microbiome compared to those without. These changes affected the normal functioning of mitochondria, leading to impaired energy production.
When examining how these changes impacted the mice's behavior, researchers found that those with a normal microbiome had compromised motor abilities compared to germ-free mice. This implies that a healthy gut environment is fundamental for maintaining optimal mitochondrial function and proper movement.
Investigating the Effect of Oxidative Stress
Oxidative stress is a condition where harmful molecules called reactive oxygen species (ROS) accumulate and damage cells. This stress has been linked to various diseases, including PD. A healthy balance of ROS is needed for cellular function, but too much can lead to serious issues.
In mice with a compromised microbiome, scientists noticed they had elevated oxidative stress levels in the brain, affecting motor abilities. To investigate further, they treated these mice with antioxidants, which helped reduce oxidative stress and improve motor function.
This finding suggests that managing oxidative stress levels in PD may be a promising avenue for treatment. If microbiome changes can boost oxidative stress, then targeting the microbiome might help to lower this damaging stress and improve symptoms in people with PD.
Mitochondrial Behavior in Mice with PD
The findings from multiple studies have shown that the behavior of mitochondria in PD models is quite interesting. In particular, mitochondria’s performance changes based on whether the mice have an active microbiome or are germ-free.
In mice with a regular microbiome, increased energy production was noted in the mitochondria, suggesting they were compensating for stress-induced by α-syn buildup. However, germ-free mice did not exhibit the same energy overactivity, indicating that the microbiome is essential for regulating mitochondrial performance.
The overall conclusion drawn from these studies is that a healthy gut can significantly impact mitochondrial function, energy production, and motor skills. When the gut environment is off-balance, it can hinder these processes, ultimately contributing to the progression of PD.
Possible Links to Treatment
With all the connections between PD, gut health, and mitochondrial function, researchers are considering new ways to approach treatment. Instead of only focusing on the brain, it may be beneficial to look into how gut health and microbiome composition can be modified to support mitochondria and overall brain health.
Emerging treatments may involve probiotics, dietary changes, or specific medications targeting the gut. These strategies could help to restore a healthy microbiome, reduce oxidative stress, and improve mitochondrial function.
Conclusion
Parkinson's disease is a complex disorder with many moving parts. Emerging evidence suggests that the gut microbiome plays a crucial role in the development and progression of the disease. In addition, the health of mitochondria, responsible for energy production in our cells, is intimately linked to gut health.
As research continues, understanding the interplay between the gut microbiome, mitochondrial function, and PD may open new avenues for treatment, giving hope to those affected by this challenging condition. While the exact causes of PD remain a mystery, focusing on gut health may lead to better management and potential breakthroughs in treating this neurodegenerative disease.
Remember, nobody wants to experience the symptoms of Parkinson's disease, but the good news is that scientists are working hard to uncover ways to combat it, one gut bacterium at a time!
Original Source
Title: The gut microbiome promotes mitochondrial respiration in the brain of a Parkinson's disease mouse model
Abstract: The pathophysiology of Parkinsons disease (PD) involves gene-environment interactions that impair various cellular processes such as autophagy, lysosomal function, or mitochondrial dysfunction. Specifically, mitochondria-associated gene mutations increase PD risk, mitochondrial respiration is altered in the PD brain, and mitochondrial-damaging toxins cause PD-like motor and gastrointestinal symptoms in animal models. The gut microbiome is altered in PD patients and represents an environmental risk, however a relationship between mitochondrial function and the microbiome in PD has not been previously established. Herein, we report that striatal mitochondria are functionally overactive in -synuclein-overexpressing (ASO) mice, a model of PD, and that microbiome depletion restores respiration and mitochondria-associated gene expression patterns to wild-type levels. ASO mice harboring a complex microbiome produce increased reactive oxygen species in the striatum whereas germ-free counterparts express elevated levels of antioxidant proteins that may buffer against oxidative damage. Indeed, antioxidant treatment improves motor performance in ASO mice and, remarkably, blocking oxidant scavenging in germ-free mice induces -synuclein-dependent motor deficits. Thus, the gut microbiome increases mitochondrial respiration and oxidative stress in the brain, which enhances motor symptoms in a mouse model of PD.
Authors: Livia H. Morais, Linsey Stiles, Milla Freeman, Anastasiya D. Oguienko, Jonathan D. Hoang, Jeff Jones, Baiyi Quan, Jack Devine, Justin S. Bois, Tsui-Fen Chou, Joanne Trinh, Martin Picard, Viviana Gradinaru, Sarkis K. Mazmanian
Last Update: 2024-12-21 00:00:00
Language: English
Source URL: https://www.biorxiv.org/content/10.1101/2024.12.18.629251
Source PDF: https://www.biorxiv.org/content/10.1101/2024.12.18.629251.full.pdf
Licence: https://creativecommons.org/licenses/by/4.0/
Changes: This summary was created with assistance from AI and may have inaccuracies. For accurate information, please refer to the original source documents linked here.
Thank you to biorxiv for use of its open access interoperability.
Reference Links
- https://www.bioinformatics.babraham.ac.uk/projects/fastqc/
- https://bioconductor.org/packages/release/bioc/html/Rsubread.html
- https://subread.sourceforge.net/featureCounts.html
- https://github.com/dtsoucas/DWLS
- https://bioconductor.org/packages/release/bioc/html/DESeq2.html
- https://bioconductor.org/packages/release/bioc/html/RITAN.html
- https://chemistry.unt.edu/~verbeck/LIMS/Manuals/XCAL_Quant.pdf
- https://www.thermofisher.com/order/catalog/product/IQLAAEGABSFAKJMAUH
- https://www.uniprot.org/help/uniprotkb
- https://noble.gs.washington.edu/proj/percolator/
- https://jeffsocal.github.io/tidyproteomics/
- https://www.broadinstitute.org/pubs/MitoCarta/
- https://www.python.org
- https://www.numpy.org
- https://pandas.pydata.org
- https://bokeh.org
- https://bebi103.github.io
- https://jupyterlab.github.io/jupyterlab/
- https://www.r-project.org/